Skip to main content
Clinical Trials/NCT01627756
NCT01627756
Completed
Not Applicable

Continued Mechanical Ventilation During CABG Operation Attenuates Systemic Immune Modulation

Medical University of Vienna1 site in 1 country30 target enrollmentApril 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Medical University of Vienna
Enrollment
30
Locations
1
Primary Endpoint
Alteration of soluble ST2 concentration in serum
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Cardiopulmonary bypass (CPB) is well known to induce a strong anti-inflammatory response. The investigators examined whether continued mechanical ventilation during CPB alters systemic immune activation.

Detailed Description

Cardiopulmonary bypass is well known to induce a strong anti-inflammatory response. Studies had been shown that the contact of blood components with artificial surfaces, the surgical trauma, endotoxemia and a reperfusion injury are in part responsible for the seen immunological affect after surgery. The purpose of this study is to test the effect of continued mechanical ventilation during surgery on a blood marker called soluble ST2 in patients sera. Soluble ST2 acts as a decoy receptor of IL-33 and has anti-inflammatory effects. Elevated soluble ST2 concentrations are reported in patients with acute myocardial infarction, sepsis, congestive heart failure and elevates soluble ST2 levels are associated with adverse outcome.

Registry
clinicaltrials.gov
Start Date
April 2009
End Date
August 2010
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hendrik Jan Ankersmit

Assoc. Prof

Medical University of Vienna

Eligibility Criteria

Inclusion Criteria

  • Written informed consent
  • age \> 40 and \< 80

Exclusion Criteria

  • treatment with steroids or immunomodulatory interventions during the past four weeks
  • signs of an acute infection

Outcomes

Primary Outcomes

Alteration of soluble ST2 concentration in serum

Time Frame: Preoperative, postoperative, day 1, day 2, day 3, day 4, day 5 after surgery

Concentration of soluble ST2 will be assessed in the serum of patient´s preoperativem, postoperative and the following five consecutive days after surgery.

Study Sites (1)

Loading locations...

Similar Trials